There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Asensus Surgical (ASXC – Research Report), Butterfly Network (BFLY – Research Report) and BioLife Solutions (BLFS – Research Report) with bullish sentiments.
Butterfly Network (BFLY)
TD Cowen analyst Josh Jennings maintained a Buy rating on Butterfly Network today. The company’s shares closed last Monday at $1.23.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of
Butterfly Network has an analyst consensus of Strong Buy, with a price target consensus of $3.63.
BioLife Solutions (BLFS)
The company’s shares closed last Monday at $16.51.
According to TipRanks.com, Mah is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
BioLife Solutions has an analyst consensus of Strong Buy, with a price target consensus of $23.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ASXC:
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
- Asensus completes in vivo Surgeon Lab for LUNA surgical robotic system
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Asensus Announces Sale of Senhance Robotic System in Romania
